NYSE - Nasdaq Real Time Price USD
Teladoc Health, Inc. (TDOC)
7.07
-0.01
(-0.15%)
As of 1:23:49 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,552,812
2,569,574
2,602,415
2,406,840
2,032,707
Cost of Revenue
753,561
751,270
760,031
743,987
650,258
Gross Profit
1,799,251
1,818,304
1,842,384
1,662,853
1,382,449
Operating Expense
1,985,901
2,027,092
2,052,885
1,890,219
1,621,437
Operating Income
-186,650
-208,788
-210,501
-227,366
-238,988
Net Non Operating Interest Income Expense
31,884
33,268
24,500
-9,270
-80,365
Other Income Expense
-870,955
-818,133
-33,607
-13,426,707
-65,303
Pretax Income
-1,025,721
-993,653
-219,608
-13,663,343
-384,656
Tax Provision
-13,353
7,592
760
-3,812
44,137
Net Income Common Stockholders
-1,012,368
-1,001,245
-220,368
-13,659,531
-428,793
Diluted NI Available to Com Stockholders
-1,012,368
-1,001,245
-220,368
-13,659,531
-428,793
Basic EPS
-5.91
-5.87
-1.34
-84.60
-2.73
Diluted EPS
-5.91
-5.87
-1.34
-84.60
-2.73
Basic Average Shares
172,169.93
170,564.09
162,169.56
161,457.12
156,939.35
Diluted Average Shares
172,169.93
170,564.09
162,169.56
161,457.12
156,939.35
Total Operating Income as Reported
-1,054,375
-1,020,886
-248,553
-13,653,214
-265,631
Total Expenses
2,739,462
2,778,362
2,812,916
2,634,206
2,271,695
Net Income from Continuing & Discontinued Operation
-1,012,368
-1,001,245
-220,368
-13,659,531
-428,793
Normalized Income
-155,939.18
-359,687.58
-190,306.92
-233,683
-377,407.57
Interest Income
55,803
57,071
46,782
12,674
776
Interest Expense
23,919
23,803
22,282
21,944
81,141
Net Interest Income
31,884
33,268
24,500
-9,270
-80,365
EBIT
-1,001,802
-969,850
-197,326
-13,641,399
-303,515
EBITDA
-629,291
-587,007
151,395
-13,373,615
-83,894
Reconciled Cost of Revenue
744,575
741,975
748,381
732,230
634,876
Reconciled Depreciation
372,511
382,843
348,721
267,784
219,621
Net Income from Continuing Operation Net Minority Interest
-1,012,368
-1,001,245
-220,368
-13,659,531
-428,793
Total Unusual Items Excluding Goodwill
-867,725
-812,098
-38,052
-13,425,848
-70,391
Total Unusual Items
-867,725
-812,098
-38,052
-13,425,848
-70,391
Normalized EBITDA
238,434
225,091
189,447
52,233
-13,503
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-11,296.18
-170,540.58
-7,990.92
0
-19,005.57
12/31/2021 - 6/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMWL American Well Corporation
6.81
-2.16%
TEM Tempus AI, Inc.
61.96
-5.00%
GDRX GoodRx Holdings, Inc.
4.4400
+4.72%
DOCS Doximity, Inc.
59.61
+0.44%
SDGR Schrödinger, Inc.
23.72
-0.67%
TXG 10x Genomics, Inc.
9.07
+5.10%
VEEV Veeva Systems Inc.
237.91
-0.68%
LFMD LifeMD, Inc.
8.06
-1.23%
TALK Talkspace, Inc.
3.0252
-0.49%
GEHC GE HealthCare Technologies Inc.
70.39
-0.16%